Nasdaq
$15.65▼ 1.23%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.67BShares out 1.100M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
20- 3d agoAfter-hours26.10.22 05:21DEFM14AOther#●●●#●●●
Personalis, Inc.
Personalis has entered into a definitive merger agreement to be acquired by Tempus AI, with a special meeting of stockholders scheduled for November 30, 2026, to approve the transaction. Upon completion, Personalis stockholders will receive Tempus Class A common stock based on a defined exchange ratio, with Tempus retaining an option to pay cash for up to 50% of the outstanding Personalis shares.…more
$15.65-1.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 4d agoPre-market26.10.21 09:48filed425Other
Personalis, Inc.
Personalis expects to complete its merger with Tempus AI in late 2026, upon which outstanding Personalis shares will be converted into Tempus Class A common stock, cash, or a combination thereof. As a result of the acquisition, the current Personalis ESPP will conclude on October 30, 2026, with no subsequent enrollment periods.…more
$15.65-1.23%vs prev closeView filingShare - 4d agoAfter-hours26.10.21 06:22425Other
Personalis, Inc.
Personalis is undergoing a merger with Tempus AI, with the transaction expected to close in late 2026. Upon completion, Personalis shares will be converted into Tempus Class A common stock or cash, and employee equity awards will be transitioned into Tempus compensation plans.…more
$15.65-1.23%vs prev closeView filingShare
19 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.7Regular26.10.08 02:44#●●●#●●●#●●●
Tempus AI Expands Cancer Vaccine Collaboration with Moderna and Merck
Tempus AI has expanded its partnership with Moderna and Merck to support the commercialization of individualized neoantigen therapies through NGS services. As the financial terms of the collaboration were not disclosed, the market impact remains neutral.…more
$15.65-1.23%vs prev closeShareBenzinga
- 8.20After-hours26.08.21 05:54
●●●●●●●● ●●●●● ●●●●●●
Personalis has received a new task order worth up to $18.3 million under its contract with the U.S. Department of Veterans Affairs for the Million Veteran Program. This addition brings the cumulative value of task orders under the program to approximately $243.3 million.…more
$15.65-1.23%vs prev closeShareBenzinga
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report